IL‐36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.

Autor: Su, Zhi1, Paulsboe, Stephanie1, Wetter, Joseph1, Salte, Katherine1, Kannan, Arun1, Gerstein, Clare1, Namovic, Marian1, Todorović, Viktor1, Edelmayer, Rebecca M.1, Leys, Laura1, Huang, Susan1, Honore, Prisca1, McGaraughty, Steve1, Scott, Victoria E.1, Mathew, Sheeba2, Horowitz, Amanda2, Seagal, Jane2, Viner, Michelle2, Rinaldi, Lisa2, Zhou, Li2
Zdroj: Experimental Dermatology. Feb2019, Vol. 28 Issue 2, p113-120. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje